Litcius/Paper detail

Probiotic peanut oral immunotherapy versus oral immunotherapy and placebo in children with peanut allergy in Australia (PPOIT-003): a multicentre, randomised, phase 2b trial

Paxton Loke, Francesca Orsini, Adriana C Lozinsky, Michael Gold, Michael D O'Sullivan, Patrick Quinn, Melanie Lloyd, Sarah E Ashley, Sigrid Pitkin, Christine Axelrad, Jessica R Metcalfe, Ee Lyn Su, Dean Tey, Marnie N Robinson, Katrina J Allen, Susan L Prescott, Audrey Dunn Galvin, Mimi L K Tang, Molly O'Sullivan, Susan Fahy-Scheer, Rachael Wallace, Samara Baldwin, Fuad Abass, Kuang-Chih Hsiao, Anne-Louise Ponsonby

2022The Lancet Child & Adolescent Health121 citationsDOIOpen Access PDF

Topics & Concepts

Oral immunotherapyMedicinePlaceboPeanut allergyImmunotherapyProbioticOral healthInternal medicineOral cavityClinical trialAllergyFood allergyOral administrationImmunologyAdverse effectRandomized controlled trialPlacebo-controlled studyMEDLINEPhases of clinical researchPeanut butterFood Allergy and Anaphylaxis ResearchProbiotics and Fermented FoodsPediatric health and respiratory diseases
Probiotic peanut oral immunotherapy versus oral immunotherapy and placebo in children with peanut allergy in Australia (PPOIT-003): a multicentre, randomised, phase 2b trial | Litcius